Alfred Altomari's most recent trade in Insmed Inc was a trade of 13,162 Common Stock done . Disclosure was reported to the exchange on May 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insmed Inc | Alfred F. Altomari | Director | 13 May 2024 | 13,162 | 69,495 (0%) | 0% | - | Common Stock | ||
| Agile Therapeutics Inc | Alfred F. Altomari | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 37,500 | 38,786 (0%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | Alfred F. Altomari | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 12,500 | 12,500 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Alfred F. Altomari | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 8,963 | 47,749 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Alfred F. Altomari | Director | 11 May 2023 | 13,192 | 56,333 (0%) | 0% | - | Common Stock | ||
| Agile Therapeutics Inc | Alfred F. Altomari | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 30,000 | 30,000 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Alfred F. Altomari | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.45 per share. | 26 Aug 2022 | 50,000 | 64,343 (0%) | 0% | 0.5 | 22,500 | Common Stock |
| Insmed Inc | Alfred F. Altomari | Director | 11 May 2022 | 14,645 | 43,141 (0%) | 0% | - | Common Stock | ||
| Agile Therapeutics Inc | Alfred F. Altomari | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 675,000 | 675,000 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Alfred Altomari | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Oct 2021 | 58,824 | 573,734 (0%) | 0% | - | Common Stock | |
| Agile Therapeutics Inc | Alfred Altomari | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Oct 2021 | 29,412 | 29,412 | - | - | Warrants (right to buy) | |
| Agile Therapeutics Inc | Alfred Altomari | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 29 Jul 2021 | 26,200 | 514,910 (0%) | 0% | 1.3 | 33,096 | Common Stock |
| Agile Therapeutics Inc | Alfred Altomari | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.61 per share. | 18 May 2021 | 20,000 | 488,710 (0%) | 0% | 1.6 | 32,200 | Common Stock |
| Insmed Inc | Alfred Altomari | Director | 12 May 2021 | 7,558 | 28,496 (0%) | 0% | - | Common Stock | ||
| Baudax Bio Inc | Alfred Altomari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2021 | 83,333 | 83,333 | - | - | Stock Option (right to buy) | |
| Baudax Bio Inc | Alfred Altomari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2021 | 56,452 | 117,785 (1%) | 0% | 0 | Common Stock | |
| Agile Therapeutics Inc | Alfred Altomari | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 23 Mar 2021 | 12,500 | 468,710 (0%) | 0% | 2.0 | 25,030 | Common Stock |
| Agile Therapeutics Inc | Alfred Altomari | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 692,641 | 692,641 | - | - | Employee Stock Option (Right to Buy) | |
| Insmed Inc | Alfred Altomari | Director | 07 Dec 2020 | 20,000 | 20,938 (0%) | 0% | 39.6 | 791,400 | Common Stock | |
| Baudax Bio Inc | Alfred Altomari | Director | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 23 Nov 2020 | 5,000 | 61,333 (0%) | 0% | 1.1 | 5,300 | Common Stock |
| Agile Therapeutics Inc | Alfred Altomari | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2020 | 94,599 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Alfred Altomari | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.76 per share. | 20 Aug 2020 | 94,599 | 456,210 (0%) | 0% | 1.8 | 166,494 | Common Stock |